(secondQuint)Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children With Partial Onset Seizures.

 The primary objective of this study is to evaluate the long-term safety and tolerability of LCM administered concomitantly with 1 to 3 Anti-Epileptic Drugs (AEDs) in subjects with epilepsy 1 month to 18 years of age who currently have uncontrolled partial onset seizures.

 The secondary objective is to evaluate the efficacy during long-term exposure to LCM in subjects epilepsy 1 month to 18 years of age.

 An additional objective is to assess behavior, cognition, quality of life, and development during long-term LCM exposure in pediatric subjects.

 Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children With Partial Onset Seizures@highlight

Study to evaluate the long-term safety and tolerability of Lacosamide (LCM) administered in addition to 1 to 3 other Anti-Epileptic Drugs in subjects with epilepsy 1 month to 18 years who currently have uncontrolled partial onset seizures.

